These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20585374)

  • 1. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.
    Kretzschmar M; Teunis PF; Pebody RG
    PLoS Med; 2010 Jun; 7(6):e1000291. PubMed ID: 20585374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    Liu Y; Zhang C; Wang Y; Luo X; Liu G; Zhang Z; Shen J
    PLoS One; 2024; 19(5):e0303508. PubMed ID: 38768133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroepidemiology of Bordetella pertussis infection in Western Europe.
    Pebody RG; Gay NJ; Giammanco A; Baron S; Schellekens J; Tischer A; Olander RM; Andrews NJ; Edmunds WJ; Lecoeur H; Lévy-Bruhl D; Maple PA; de Melker H; Nardone A; Rota MC; Salmaso S; Conyn-van Spaendonck MA; Swidsinski S; Miller E
    Epidemiol Infect; 2005 Feb; 133(1):159-71. PubMed ID: 15724723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological evaluation of Bordetella pertussis infection in adults with prolonged cough].
    Sönmez C; Çöplü N; Gözalan A; Yılmaz Ü; Bilekli S; Demirci NY; Biber Ç; Erdoğan Y; Esen B; Çöplü L
    Mikrobiyol Bul; 2016 Jul; 50(3):361-70. PubMed ID: 27525392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
    Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
    Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries.
    Wehlin L; Ljungman M; Kühlmann-Berenzon S; Galanis I; Huygen K; Pierard D; Dalby T; Petridou E; Molnár Z; Carollo M; Ausiello CM; Lipnickiene V; Haider J; Aase A; Herstad TK; Rastawicki W; Rio C; Popovici O; De Ory Manchon F; Bacci S; Barkoff AM; Hänninen A; He Q; Hallander H
    APMIS; 2021 Sep; 129(9):556-565. PubMed ID: 34120372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.
    Aase A; Herstad TK; Merino S; Brandsdal KT; Berdal BP; Aleksandersen EM; Aaberge IS
    Clin Vaccine Immunol; 2007 Jul; 14(7):855-62. PubMed ID: 17507542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of whooping cough in the Czech Republic: estimates of incidence of infection in adults.
    Chlibek R; Smetana J; Sosovickova R; Fabianova K; Zavadilova J; Dite P; Gal P; Naplava P; Lzicarova D
    Public Health; 2017 Sep; 150():77-83. PubMed ID: 28646697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark.
    Rønn PF; Dalby T; Simonsen J; Jørgensen CS; Linneberg A; Krogfelt KA
    Epidemiol Infect; 2014 Apr; 142(4):729-37. PubMed ID: 24103353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries.
    Berbers G; van Gageldonk P; Kassteele JV; Wiedermann U; Desombere I; Dalby T; Toubiana J; Tsiodras S; Ferencz IP; Mullan K; Griskevicius A; Kolupajeva T; Vestrheim DF; Palminha P; Popovici O; Wehlin L; Kastrin T; Maďarová L; Campbell H; Ködmön C; Bacci S; Barkoff AM; He Q;
    Nat Commun; 2021 May; 12(1):2871. PubMed ID: 34001895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
    Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
    Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.
    Saffar MJ; Khalilian AR; Rafee AR; Parsaei MR; Imanikhani S; Shojaei J; Saffar H
    Indian J Pediatr; 2012 Mar; 79(3):353-7. PubMed ID: 22105235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.